Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
PIK3CA mutations are associated with pathologic complete response rate to neoadjuvant pyrotinib and trastuzumab plus chemotherapy for HER2-positive breast cancer.
Shi Q, Xuhong J, Luo T, Ge J, Liu F, Lan Y, Chen Q, Tang P, Fan L, Chen L, Liang Y, Wang M, Hu Y, Zhang Y, Bian X, Qi X, Jiang J. Shi Q, et al. Among authors: luo t. Br J Cancer. 2023 Jan;128(1):121-129. doi: 10.1038/s41416-022-02021-z. Epub 2022 Nov 2. Br J Cancer. 2023. PMID: 36323880 Free PMC article.
Autopsy analysis reveals increased macrophage infiltration and cell apoptosis in COVID-19 patients with severe pulmonary fibrosis.
Xiao SQ, Wen TZ, Chen XY, Chen HY, Li Z, He ZC, Luo T, Tang R, Fu WJ, Cao MF, Chen L, Niu Q, Wang S, Lan Y, Ge J, Li QR, Guo HT, Wang YX, Ping YF, Shen H, Wang Y, Ding YQ, Bian XW, Yao XH. Xiao SQ, et al. Among authors: luo t. Pathol Res Pract. 2023 Dec;252:154920. doi: 10.1016/j.prp.2023.154920. Epub 2023 Nov 4. Pathol Res Pract. 2023. PMID: 37948998 Free article.
Safety and efficacy of anlotinib combined with taxane and lobaplatin in neoadjuvant treatment of clinical stage II/III triple-negative breast cancer in China (the neoALTAL trial): a single-arm, phase 2 trial.
Liang Y, Liu J, Ge J, Shi Q, Zhang G, Wan A, Luo T, Tian H, Fan L, Wang S, Chen L, Tang P, Zhu K, Jiang J, Bian X, Zhang Y, Qi X. Liang Y, et al. Among authors: luo t. EClinicalMedicine. 2024 Apr 11;71:102585. doi: 10.1016/j.eclinm.2024.102585. eCollection 2024 May. EClinicalMedicine. 2024. PMID: 38638401 Free PMC article.
Punicalagin attenuates isoproterenol-induced myocardial infarction through nuclear factor erythroid 2-related factor 2/silent information regulator transcript-1-mediated inhibition of inflammation and cardiac stress markers in experimental animal models.
Liao XY, Liu P, Luo TF, Li Y, Gao Y, Pan FY, Wang KC. Liao XY, et al. Among authors: luo tf. J Physiol Pharmacol. 2024 Apr;75(2):123-136. doi: 10.26402/jpp.2024.2.02. Epub 2024 May 6. J Physiol Pharmacol. 2024. PMID: 38736260
3,621 results